Wound Care Market is projected to grow at a compound annual growth rate (CAGR) of 4.17% from 2024 to 2030

Comments · 35 Views

Diabetes-related complications, such as diabetic foot ulcers, are a major focus in wound care due to their potential severity. Diabetic foot ulcers, if not treated promptly and effectively, can lead to infections and, in severe cases, require amputation.

The global wound care market was valued at USD 22.25 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 4.17% from 2024 to 2030. The market’s growth is largely driven by a rise in the number of surgical procedures and the growing prevalence of chronic diseases worldwide. With an aging global population and increased incidence of conditions like diabetes, the need for effective wound care products is intensifying. Sedentary lifestyles and poor dietary habits have also contributed to a rise in chronic diseases such as diabetes, which often lead to complications like diabetic foot ulcers, thereby increasing demand for wound care solutions. According to the Centers for Disease Control and Prevention (CDC), as of April 2023, 37.3 million Americans had diabetes, with an additional 96 million Americans identified as having prediabetes. The high prevalence of diabetes is one of the significant drivers of the wound care market, particularly due to its association with complications like foot ulcers.

 

Diabetes-related complications, such as diabetic foot ulcers, are a major focus in wound care due to their potential severity. Diabetic foot ulcers, if not treated promptly and effectively, can lead to infections and, in severe cases, require amputation. According to the National Institutes of Health (NIH), diabetes remains a leading cause of non-traumatic amputations in the U.S., with approximately 5% of diabetic patients developing foot ulcers, and around 1% of those cases progressing to the point of requiring amputation. Advanced wound care products like hydrocolloid dressings play a critical role in the management and treatment of such wounds. These dressings help maintain a moist wound environment, promote rapid healing, and assist in the absorption of necrotic tissue, which is essential for preventing infections, particularly in post-surgical cases. As healthcare professionals increasingly opt for advanced wound care solutions for treating both chronic and acute wounds, the market is poised for continued growth during the forecast period.

 

Gather more insights about the market drivers, restrains and growth of the Wound Care Market

 

Product Insights

 

The global wound care market is segmented into several categories, including advanced wound dressings, surgical wound care, traditional wound care, and wound therapy devices. Among these, the advanced wound dressing segment captured the largest share, accounting for 34.9% of the total market in 2023. This segment is also expected to witness the highest growth rate during the forecast period, largely due to its effectiveness in treating chronic and non-healing wounds such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers. These types of dressings, including hydrocolloids, alginates, and foam dressings, are designed to provide an optimal healing environment by maintaining moisture, absorbing exudate, and preventing bacterial contamination. Their growing adoption can be attributed to the rising incidence of chronic wounds globally. According to the National Center for Biotechnology Information (NCBI), as of August 2023, the global incidence of diabetic foot ulcers ranged between 9.1 million and 26.1 million cases, with 15% to 25% of diabetic patients expected to develop a foot ulcer at some point in their lifetime. As such, the increasing prevalence of diabetic wounds will continue to drive the demand for advanced wound care products.

 

The surgical wound care segment is also expected to grow significantly, with a projected growth rate of 4.30% over the forecast period. This growth is largely due to the rising number of surgical procedures globally and the associated risk of surgical site infections (SSIs). According to a report by the National Institutes of Health (NIH) published in January 2023, SSIs affect between 0.5% and 3% of patients undergoing surgery, with the risk varying depending on the type of surgery and patient conditions. As the number of surgical procedures continues to increase due to aging populations, trauma cases, and elective surgeries, the need for effective surgical wound care products, such as antimicrobial dressings and topical treatments, will rise. This will further boost the segment’s growth in the coming years.

 

Challenges

 

Despite the positive growth outlook, there are challenges facing the wound care market. The high cost of advanced wound care products can be a barrier to adoption, especially in developing regions where healthcare budgets are limited. While advanced dressings and therapies offer superior healing outcomes, their cost compared to traditional treatments can be prohibitive for some patients and healthcare providers.

 

Additionally, there is a lack of awareness among patients and healthcare providers in certain regions about the benefits of advanced wound care products. This can result in the continued reliance on traditional wound care methods, which may not provide the same level of efficacy, particularly for chronic or severe wounds.

 

Order a free sample PDF of the Market Intelligence Study, published by Grand View Research.

 

Comments